Retroviral infection (HIV) - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱ 7 min read ✅ Medically reviewed
```html Retroviral Infection (HIV) – Comprehensive Medical Guide

Retroviral Infection (HIV) – A Comprehensive Medical Guide

Overview

Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the immune system, specifically CD4âș T‑lymphocytes, which are essential for fighting infections. If left untreated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS), a condition in which the body can no longer defend itself against opportunistic infections and certain cancers.

Who it affects: HIV does not discriminate by age, gender, race, or socio‑economic status. However, global data show higher prevalence in certain groups:

  • Men who have sex with men (MSM)
  • People who inject drugs
  • Sex workers and their clients
  • Individuals in regions with high generalized epidemics, such as sub‑Saharan Africa

Prevalence: According to the World Health Organization (WHO), an estimated 38 million people worldwide were living with HIV in 2023, with about 1.5 million new infections that year. In the United States, the CDC reports roughly 1.2 million people living with HIV, and roughly 13,000 new diagnoses annually.

Symptoms

HIV infection progresses through three stages—acute infection, clinical latency, and AIDS—each with distinct symptom patterns. Not everyone experiences every symptom, and many people remain asymptomatic for years.

Acute (Primary) HIV Infection (2‑4 weeks after exposure)

  • Fever – often the first sign, resembling flu.
  • Rash – usually a non‑itchy, maculopapular rash on the trunk.
  • Fatigue – severe tiredness not explained by activity.
  • Sore throat – may be mistaken for strep.
  • Muscle and joint aches
  • Swollen lymph nodes – especially in the neck, armpits, and groin.
  • Headache
  • Oral ulcers – small, painful sores.
  • Gastrointestinal upset – nausea, vomiting, diarrhea.

Clinical Latency (Chronic HIV)

During this stage, the virus is actively replicating, but symptoms may be mild or absent. Some people notice:

  • Persistent, low‑grade fever
  • Night sweats
  • Unexplained weight loss
  • Recurrent fungal infections (e.g., oral thrush)
  • Swollen lymph nodes lasting >3 months

AIDS‑defining Illnesses (CD4 count <200 cells/mm³)

  • Severe or chronic diarrhea
  • Pneumocystis jirovecii pneumonia (PCP)
  • Kaposi sarcoma (purple skin lesions)
  • Cytomegalovirus (CMV) retinitis – can cause vision loss
  • Non‑Hodgkin lymphoma
  • Cryptococcal meningitis
  • Recurrent severe bacterial infections (e.g., TB, bacterial pneumonia)

Causes and Risk Factors

Cause: HIV is transmitted through the exchange of certain body fluids that contain a sufficient amount of virus:

  • Blood
  • Semen and pre‑ejaculate
  • Vaginal fluids
  • Breast milk (primarily during breastfeeding)

Unlike some viruses, HIV cannot be spread through casual contact (e.g., hugging, sharing dishes) or through the air.

Major Risk Factors

  • Unprotected sexual activity – especially anal intercourse
  • Sharing needles or syringes – for illicit drug use, tattoos, or piercings
  • Mother‑to‑child transmission – during pregnancy, delivery, or breastfeeding
  • Receiving contaminated blood products – rare in countries with rigorous screening
  • High‑prevalence environments – living in or traveling to regions with high HIV rates increases exposure risk

Additional factors that can increase susceptibility include existing sexually transmitted infections (STIs), mucosal injuries, and the presence of genital ulcer disease.

Diagnosis

Early detection is crucial because treatment can start before symptoms appear, preserving immune function and reducing transmission risk.

Screening Tests

  • Fourth‑generation antigen/antibody combo test – detects HIV‑1/2 antibodies and p24 antigen; can identify infection as early as 2‑4 weeks after exposure.
  • Rapid point‑of‑care tests – provide results in 20‑30 minutes; useful in community settings.

Confirmatory Testing

If a screening test is reactive, a laboratory‑based nucleic acid test (NAT) or an HIV‑1/HIV‑2 differentiation assay is performed to confirm infection and determine the viral type.

Monitoring Disease Progression

  • CD4âș T‑cell count – measured in cells per cubic millimeter; guides treatment decisions and prophylaxis for opportunistic infections.
  • Viral load (RNA PCR) – quantifies HIV copies per milliliter of blood; used to assess treatment effectiveness.
  • Resistance testing – genotypic/phenotypic assays performed before starting therapy or after treatment failure.

Treatment Options

Current therapy is called antiretroviral therapy (ART)**, a lifelong regimen of ≄3 drugs from at least two different classes. Modern ART is highly effective, enabling >95% of patients to achieve undetectable viral loads within 6‑12 months.

First‑Line Regimens (2024 NIH Guidelines)

  • Integrase strand transfer inhibitor (INSTI) + two nucleoside reverse transcriptase inhibitors (NRTIs) – e.g., Dolutegravir + Tenofovir alafenamide/Emtricitabine
  • Alternative: Bictegravir (single‑tablet regimen) + NRTIs

Second‑Line/Salvage Options

  • Protease inhibitors (PIs) – e.g., Darunavir/ritonavir
  • Non‑nucleoside reverse transcriptase inhibitors (NNRTIs) – e.g., Etravirine
  • Entry inhibitors – e.g., Maraviroc (CCR5 antagonist)
  • Long‑acting injectable formulations – Cabotegravir + Rilpivirine (administered monthly or bimonthly)

Adjunctive Care

  • Vaccinations (influenza, pneumococcal, HPV, hepatitis B)
  • Prophylaxis for opportunistic infections (e.g., Trimethoprim‑sulfamethoxazole for PCP when CD4 <200)
  • Lifestyle counseling – smoking cessation, substance use treatment, nutrition

Side‑Effect Management

Most modern agents are well tolerated, but common issues include:

  • Gastrointestinal upset (nausea, diarrhea)
  • Insomnia or vivid dreams (especially with efavirenz)
  • Weight gain (particularly with integrase inhibitors)
  • Renal or bone effects with tenofovir disoproxil fumarate (TDVF) – consider tenofovir alafenamide (TAF) if risk high

Discuss any new symptoms with your provider; many side effects are manageable by switching agents.

Living with Retroviral Infection (HIV)

Adopting a proactive approach helps maintain health, prolong life expectancy (average >75 years with effective ART), and reduce transmission risk.

Medication Adherence

  • Take meds at the same time each day—set alarms or use pillboxes.
  • Link dosing with a daily habit (e.g., brushing teeth).
  • Discuss any barriers (cost, side effects, stigma) with your care team.

Regular Medical Follow‑up

  • Every 3–6 months: CD4 count, viral load, and review of comorbidities.
  • Annual screenings: lipid profile, liver/kidney function, bone density (if risk factors).
  • Routine STI testing and vaccinations.

Nutrition & Exercise

  • Balanced diet rich in fruits, vegetables, lean protein, and whole grains.
  • Limit processed foods high in saturated fats and sugars.
  • Aim for at least 150 minutes of moderate aerobic activity per week.

Mental Health

  • Address depression, anxiety, or HIV‑related stigma with counseling or support groups.
  • Mind‑body techniques (meditation, yoga) can improve adherence and quality of life.

Social & Legal Considerations

  • Know your rights: many jurisdictions have anti‑discrimination laws protecting people with HIV.
  • Consider disclosing status to trusted partners; use “U=U” (Undetectable = Untransmittable) messaging.
  • Explore patient assistance programs for medication cost support.

Prevention

Prevention strategies target both acquiring and transmitting HIV.

Primary Prevention

  • Condom use – consistent, correct use reduces risk by ~80%.
  • Pre‑Exposure Prophylaxis (PrEP) – daily Tenofovir/emtricitabine (Truvada) or Descovy; >99% effective when adhered to.
  • Post‑Exposure Prophylaxis (PEP) – 28‑day antiretroviral course started within 72 h after potential exposure.
  • Needle‑syringe programs and opioid substitution therapy for people who inject drugs.
  • Male circumcision reduces heterosexual acquisition risk by ~60% (WHO evidence).

Secondary Prevention (Reducing Transmission)

  • Achieve and maintain an undetectable viral load (U=U).
  • Use condoms even when viral load is suppressed, especially with new partners.
  • Screen and treat STIs promptly.
  • Encourage HIV‑negative partners to consider PrEP.

Complications

If HIV remains untreated or poorly controlled, a range of complications may develop.

Opportunistic Infections (OIs)

  • Pneumocystis jirovecii pneumonia (PCP)
  • Cytomegalovirus (CMV) retinitis or colitis
  • Mycobacterium avium complex (MAC) infection
  • Cryptococcal meningitis
  • Disseminated histoplasmosis

Malignancies

  • Kaposi sarcoma
  • Non‑Hodgkin lymphoma
  • Invasive cervical cancer

Non‑Infectious Comorbidities

  • Cardiovascular disease – accelerated atherosclerosis
  • Chronic kidney disease – especially with tenofovir exposure
  • Liver disease – hepatitis B/C co‑infection, fatty liver
  • Neurocognitive disorders – HIV‑associated neurocognitive disorder (HAND)
  • Bone loss – osteopenia/osteoporosis

Pregnancy‑Related Issues

Without ART, mother‑to‑child transmission rates can be 15‑45%; effective therapy reduces this to <1%.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe shortness of breath or chest pain
  • High fever (>39°C / 102°F) with stiff neck or severe headache (possible meningitis)
  • Rapid onset of confusion, seizures, or loss of consciousness
  • Profuse, watery diarrhea lasting >24 hours leading to dehydration
  • Severe, unexplained bruising or bleeding (possible thrombocytopenia)
  • Unexplained, rapid weight loss (>10% of body weight in a month)
  • Sudden vision changes or eye pain (possible CMV retinitis)
  • Persistent vomiting preventing you from keeping fluids down

These symptoms may signal life‑threatening opportunistic infections or complications that require immediate medical attention.

References

  • World Health Organization. Global HIV & AIDS statistics — 2023 Fact sheet.
  • Centers for Disease Control and Prevention. HIV Basics.
  • National Institutes of Health. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. 2024 update.
  • Mayo Clinic. HIV/AIDS – Symptoms, causes, and treatment.
  • Cleveland Clinic. Living with HIV: Lifestyle and coping strategies.
  • UNAIDS. Combined HIV Strategic Plan 2022‑2026.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References